naltrexone has been researched along with Crohn Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lie, MRKL; Paulides, E; van der Woude, CJ | 1 |
| Berlau, DJ; Patten, DK; Schultz, BG | 1 |
| Raknes, G; Simonsen, P; Småbrekke, L | 1 |
| Chande, N; MacDonald, JK; Nguyen, TM; Parker, CE; Segal, D | 1 |
| Feng, J; Griffin, N; Li, Z; Shan, F; You, Y | 1 |
| Jackson, WE; Lashner, BA; Rizk, M | 1 |
| Chande, N; Macdonald, JK; Segal, D | 1 |
| Weinstock, LB | 1 |
| Handberg, G; Plesner, KB; Vægter, HB | 1 |
| Abdel-Salam, LO; Kamel, MM; Khattab, A; Osman, AS; Tawfik, DI; Tolba, HM | 1 |
| Alkhouri, N; Kaplan, B; Mahajan, L; Mayacy, S; Shannon, A | 1 |
| Bingaman, SI; Mauger, DT; McGovern, CO; Mukherjee, A; Ruggiero, F; Smith, JP; Zagon, IS | 1 |
| Giverhaug, T; Raknes, G | 1 |
| McLaughlin, PJ; Zagon, IS | 1 |
| Bingaman, SI; Evans, R; Field, D; Mauger, DT; Smith, JP | 1 |
| Bingaman, S; Mauger, D; Rogosnitzky, M; Smith, JP; Stock, H; Zagon, IS | 1 |
5 review(s) available for naltrexone and Crohn Disease
| Article | Year |
|---|---|
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.
Topics: Animals; Anti-Inflammatory Agents; Chronic Pain; Crohn Disease; Dose-Response Relationship, Drug; Fibromyalgia; Humans; Inflammation; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Quality of Life | 2018 |
Low dose naltrexone for induction of remission in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Humans; Induction Chemotherapy; Intention to Treat Analysis; Naltrexone; Randomized Controlled Trials as Topic | 2018 |
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy.
Topics: Analgesics, Opioid; Animals; Autoimmunity; Crohn Disease; Drug Dosage Calculations; Humans; Immunologic Factors; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Neoplasms; Off-Label Use; Receptors, Opioid; Substance Abuse Treatment Centers | 2018 |
Low dose naltrexone for induction of remission in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Crohn Disease; Humans; Induction Chemotherapy; Naltrexone; Randomized Controlled Trials as Topic | 2014 |
[Low dose naltrexone for treatment of pain].
Topics: Analgesics, Opioid; Crohn Disease; Fibromyalgia; Humans; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Pain | 2015 |
3 trial(s) available for naltrexone and Crohn Disease
| Article | Year |
|---|---|
Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn's disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study.
Topics: Crohn Disease; Humans; Inflammation; Inflammatory Bowel Diseases; Multicenter Studies as Topic; Naltrexone; Randomized Controlled Trials as Topic; Remission Induction | 2022 |
Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.
Topics: Adult; Aged; Colonoscopy; Crohn Disease; Fatigue; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study.
Topics: Administration, Oral; Adolescent; Age Factors; Child; Crohn Disease; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Pennsylvania; Pilot Projects; Quality of Life; Remission Induction; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2013 |
8 other study(ies) available for naltrexone and Crohn Disease
| Article | Year |
|---|---|
The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Databases, Factual; Drug Prescriptions; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Norway; Off-Label Use; Tumor Necrosis Factor-alpha | 2018 |
Avoiding narcotics in Crohn's disease.
Topics: Crohn Disease; Female; Humans; Male; Naltrexone; Narcotic Antagonists | 2013 |
Naltrexone therapy for Crohn's disease and ulcerative colitis.
Topics: Crohn Disease; Female; Humans; Male; Naltrexone; Narcotic Antagonists | 2014 |
Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats.
Topics: Animals; Crohn Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ileum; Indomethacin; Intestinal Mucosa; Male; Naltrexone; Narcotic Antagonists; Rats; Sulfasalazine; Treatment Outcome | 2016 |
Low-dose naltrexone for treatment of duodenal Crohn's disease in a pediatric patient.
Topics: Adolescent; Crohn Disease; Dose-Response Relationship, Drug; Duodenal Diseases; Female; Humans; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2010 |
[Naltrexone--high expectations to low dosages].
Topics: Crohn Disease; Dose-Response Relationship, Drug; Humans; Multiple Sclerosis; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2011 |
Targeting opioid signaling in Crohn's disease: new therapeutic pathways.
Topics: Analgesics, Opioid; B-Lymphocytes; Cell Proliferation; Crohn Disease; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid; Signal Transduction; T-Lymphocytes | 2011 |
Low-dose naltrexone therapy improves active Crohn's disease.
Topics: Adult; Blood Sedimentation; C-Reactive Protein; Crohn Disease; Endoscopy, Gastrointestinal; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Naltrexone; Pilot Projects; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2007 |